Olaparib Maintenance Therapy in Metastatic Breast Cancer

Clinical trial NCT05629429 · UNKNOWN

Trial details

NCT number: NCT05629429
Sponsor: National Taiwan University Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2023-02-07
Primary completion: 2025-12-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.